About this trial
This study aims to investigate the effects of a combined exercise program on chronic pain in postmenopausal women, considering insulin resistance as a potential physiological mediator. The intervention will assess changes in pain intensity, metabolic and inflammatory biomarkers, psychosocial factors, and body composition. The findings may contribute to understanding the metabolic mechanisms underlying chronic pain in postmenopausal women and support exercise as a non-pharmacological therapeutic strategy.
Eligibility criteria
Qualifiers
Postmenopausal women, defined as between 12 months and 5 years since the last menstrual period.
Not using hormone replacement therapy.
Not engaged in regular physical exercise (defined as more than once per week in the last months).
With or without insulin resistance.
Disqualifiers
Diagnosis of neurological diseases (e.g., Parkinson's disease, multiple sclerosis, or stroke sequelae).
Severe psychiatric disorders.
Inflammatory autoimmune diseases (e.g., rheumatoid arthritis or systemic lupus erythematosus).
Active neoplasms.
Trial design
Treatments tested in this trial
- Combined Exercise Program
- Usual Care Group